The GA + Gem group showed minimal proliferating cell nuclear antigen (PCNA) marker staining (27%) compared to control (95%), GA (86%), and Gem (42%) treatments in vivo, indicating that tumor cell proliferation was suppressed by the GA + Gem group. The gene discussed is PCNA; the disease is neoplasm.